← FDA DRUG APPROVALS

FDA ANDA · ANDA200181

PHENELZINE SULFATE

Sponsor: NOVEL LABS INC

APPLICATION
ANDA200181
TYPE
ANDA
ORIGINAL APPROVAL
2010-12-08
LATEST ACTION
2014-07-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PHENELZINE SULFATEPrescription
PHENELZINE SULFATE EQ 15MG BASE · TABLET · ORAL

Approval history

2014-07-17Labeling · Supplement 2 · standardAP
2010-12-08OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →